Number of shares outstanding for ChemoCentryx (CCXI)

Number of shares outstanding in June 2022 : 71,234,000

According to ChemoCentryx's latest financial reports and stock price the company's current number of shares outstanding is 71,234,000. At the end of 2022 the company had 71,234,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for ChemoCentryx from 2011 to 2022

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2022	71.23 M	1.6%
2021	70.11 M	1.24%
2020	69.25 M	17.5%
2019	58.93 M	16.66%
2018	50.52 M	3.72%
2017	48.7 M	1.69%
2016	47.9 M	8.51%
2015	44.14 M	1.75%
2014	43.38 M	1.18%
2013	42.87 M	18.19%
2012	36.27 M	27.42%
2011	28.47 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Biogen BIIB	145,600,000	104.40%	🇺🇸 USA
AbbVie ABBV	1,768,000,000	2,381.96%	🇺🇸 USA
GlaxoSmithKline GSK	2,034,500,000	2,756.08%	🇬🇧 UK
Bristol-Myers Squibb BMY	2,027,000,000	2,745.55%	🇺🇸 USA
Johnson & Johnson JNJ	2,406,800,000	3,278.72%	🇺🇸 USA
Amgen AMGN	537,000,000	653.85%	🇺🇸 USA
Pfizer PFE	5,666,000,000	7,854.07%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	1,133,000,000	1,490.53%	🇮🇱 Israel
Merck MRK	2,535,649,470	3,459.61%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions